Darae Ko Selected Research

Darae Ko Research Topics

12	Atrial Fibrillation 11/2023 - 05/2014
9	Stroke (Strokes) 01/2024 - 05/2014
4	Frailty 11/2023 - 01/2023
4	Heart Failure 10/2023 - 11/2017
4	Venous Thromboembolism 01/2023 - 09/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2023
3	Myocardial Infarction 11/2022 - 11/2017
2	Heart Diseases (Heart Disease) 01/2024 - 01/2023
2	Diabetes Mellitus 01/2018 - 11/2017
1	Obesity 01/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Hip Fractures (Intertrochanteric Fractures) 12/2023
1	ST Elevation Myocardial Infarction 11/2023
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2023
1	Myocarditis (Carditis) 11/2021
1	Sepsis (Septicemia) 11/2021
1	Pericarditis 11/2021
1	Pneumonia (Pneumonitis) 11/2021
1	Pneumothorax 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 11/2021
1	Thyrotoxicosis 11/2021
1	Embolic Stroke 01/2021
1	Ischemic Stroke 01/2021
1	Cerebral Hemorrhage 08/2018
1	Insulin Resistance 01/2018
1	Orthostatic Hypotension (Postural Hypotension) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Thromboembolism 04/2017
1	Infarction (Infarctions) 01/2017
1	Inflammation (Inflammations) 01/2015
1	Thrombophilia 01/2015
1	Hemorrhage 09/2014

6	AnticoagulantsIBA 11/2023 - 05/2014
4	Warfarin (Coumadin)FDA LinkGeneric 11/2023 - 05/2014
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
2	CholesterolIBA 01/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2023
2	Antihypertensive Agents (Antihypertensives)IBA 11/2022 - 11/2017
2	Vitamin K FDA Link 08/2018 - 05/2014
1	lecanemabIBA 01/2024
1	omega-Chloroacetophenone (Mace)IBA 12/2023
1	Prasugrel Hydrochloride FDA Link 11/2023
1	Clopidogrel (Plavix)FDA Link 11/2023
1	TicagrelorIBA 11/2023
1	apixabanIBA 11/2023
1	RivaroxabanIBA 11/2023
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2023
1	AngiotensinsIBA 10/2023
1	Neprilysin (Neutral Endopeptidase)IBA 10/2023
1	Mineralocorticoid Receptor AntagonistsIBA 10/2023
1	ReninIBA 10/2023
1	chemotactic factor inactivatorIBA 01/2023
1	EicosanoidsIBA 11/2022
1	danaparoid (Orgaran)FDA Link 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020
1	Liraglutide FDA Link 01/2018
1	hydroxide ionIBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017

8	Therapeutics 10/2023 - 09/2014
1	Percutaneous Coronary Intervention 11/2023
1	Precision Medicine 01/2023
1	Length of Stay 01/2023
1	Secondary Prevention 01/2021
1	Anticoagulation Reversal 08/2018